Commodore Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $108M | Sell |
|
|||||
|
2025
Q2 | $94.7M | Buy |
|
|||||
|
2025
Q1 | $78M | Sell |
|
|||||
|
2024
Q4 | $107M | Buy |
|
|||||
|
2024
Q3 | $106M | Sell |
|
|||||
|
2024
Q2 | $107M | Buy |
|
|||||
|
2024
Q1 | $93.3M | Hold |
|
|||||
|
2023
Q4 | $99.8M | Buy |
|
|||||
|
2023
Q3 | $63M | Hold |
|
|||||
|
2023
Q2 | $71M | Hold |
|
|||||
|
2023
Q1 | $66M | Buy |
|
|||||
|
2022
Q4 | $65.4M | Buy |
|
|||||
|
2022
Q3 | $57.6M | Hold |
|
|||||
|
2022
Q2 | $48.5M | Buy |
|
|||||
|
2022
Q1 | $36.8M | Buy |
|
|||||
|
2021
Q4 | $34.1M | Buy |
|
|||||
|
2021
Q3 | $8.85M | Buy |
|
|||||
|
2021
Q2 | $6.08M | Buy |
|
|||||
|
2021
Q1 | $5.39M | Sell |
|
|||||
|
2020
Q4 | $7.19M | Buy |
|